They identified an LDHA–H4K12la–immune-gene axis that links glycolytic metabolism, epigenetic regulation and immune signaling, highlighting this pathway as a potential target for therapeutic intervention in pancreatic cancer. The gene discussed is LDHA; the disease is pancreatic neoplasm.